Enliven Therapeutics, Inc.

NASDAQ:ELVN

Biotechnology

Healthcare
$46.41 -0.27%

-$0.12 today

Market cap
$3.42B
Beta
0.40
P/E (TTM)
-28.4
EPS (TTM)
-$1.57
52W Low $14.79High $48.53

Volume 0.99M

Average 1.35M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$119.66M

FY 2025 · Annual

Net Income

-$103.69M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0000263K
Gross Profit0000(263K)
Gross Margin—————
Research & Development20.47M31.02M64.57M80.78M85.86M
Selling, General & Admin4.29M7.77M18.96M23.78M33.8M
Operating Expenses24.76M38.79M83.53M104.55M119.4M
Depreciation & Amortization115K215K297K317K263K
EBITDA(24.63M)(37.45M)(71.29M)(88.48M)(103.43M)
EBITDA Margin—————
Operating Income(24.76M)(38.79M)(83.53M)(104.55M)(119.66M)
Operating Margin—————
Interest Income22K1.13M11.97M14.89M16.01M
Interest Expense00000
Other Income / Expenses22K1.13M11.95M15.76M15.96M
Income Before Tax(24.74M)(37.66M)(71.58M)(88.79M)(103.69M)
Pre-Tax Margin—————
Income Tax Expense000232K0
Net Income(24.74M)(37.66M)(71.58M)(89.02M)(103.69M)
Net Margin—————
EPS (Basic)(3.17)(6.03)(2.01)(1.89)(1.83)
EPS (Diluted)(3.17)(6.03)(2.01)(1.89)(1.83)
Weighted Avg Shares7.81M6.25M35.55M47.07M56.66M
Weighted Avg Shares (Diluted)7.82M6.25M35.55M47.07M56.66M

ELVN Earnings Waterfall · TTM

NASDAQ:ELVN · Revenue to Net Income

Key Ratios

EPS$-1.68
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-23.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$113.5M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.68, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
4Statement of changes in beneficial ownershipOct 21, 2026

How much revenue does ELVN generate?

Enliven Therapeutics, Inc. (ELVN) reported $0.00 of revenue in fiscal 2025.

Is ELVN profitable?

Enliven Therapeutics, Inc. (ELVN) reported -$103.69M of net income.